Group 1 - Jizhi Co., Ltd. plans to acquire at least 51% equity in Pumai Technology through cash payment, aiming to gain control over the company, which is a leading enterprise in the field of robot performance testing and calibration in China [1] - Yaxing Chemical's subsidiary intends to transfer 7.14% equity for 60 million yuan to another fund under the same control, indicating strategic investment movements within the same management group [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Sentai Co., Ltd.'s controlling shareholder plans to increase shareholding by at least 100 million yuan within 12 months, aiming to enhance confidence in the company's future [4] - Health元's subsidiary has received acceptance for the marketing authorization application of Lecanemab injection, which is intended for moderate to severe plaque psoriasis patients [5][11] - Sunshine Nuohuo has signed a technical development contract for the STC008 injection project, with a total payment of 500 million yuan, indicating significant investment in cancer treatment [6] Group 3 - Hunan YN has been designated as a delivery warehouse for lithium carbonate by the Guangzhou Futures Exchange, enhancing its position in the lithium market [7] - Tianji Co., Ltd. is pushing for the industrialization of lithium sulfide material preparation, although it faces risks in commercialization [8] - Yuandong Bio has received FDA approval for Methylene Blue injection, expanding its product portfolio in the U.S. market [10] Group 4 - Nanshan Aluminum has established a wholly-owned subsidiary in Hainan with an investment of 5 million yuan, focusing on high-end aluminum products [13] - ST Xifa plans to acquire 50% equity in Lhasa Beer, aiming for full ownership, with the transaction currently in the planning stage [14] - Hengrui Medicine's SHR-A1904 injection has been included in the list of breakthrough therapy products, indicating its potential in treating advanced gastric cancer [12] Group 5 - Chengdu Gas is planning to merge three subsidiaries, streamlining operations and enhancing efficiency [26] - Baoli Electric intends to invest 50 million yuan to establish a wholly-owned subsidiary focused on key equipment and solutions in energy storage [27] - Huadian International has successfully put the second unit of its Longkou Phase IV project into commercial operation, marking a significant milestone in its energy production capacity [34]

集智股份（300553）(300553.SZ)发布公告，近日，公司与自然人陈章位、沈慧、张翔、杭州亿恒科技 有限公司(以下统称"转让方")签署《杭州集智机电股份有限公司对浙江谱麦科技有限公司之收购意向协 议》(以下简称"《收购意向协议》")，公司拟以支付现金的方式收购浙江谱麦科技有限公司(以下简 称"标的公司"或"谱麦科技")不低于51%股权并取得谱麦科技控股权。 谱麦科技自成立以来主要专注于机器人性能检测与校准技术研究与应用，提供机器人性能检测与校准、 机器人抖动测量与分析、机器人可靠性试验、机器人动力学参数辨识和优化分析、机器人性能视觉检测 系统等产品，为客户提供定制化智能装备检测解决方案及可靠性分析和试验服务。 ...

智通财经APP讯，集智股份(300553.SZ)发布公告，近日，公司与自然人陈章位、沈慧、张翔、杭州亿恒 科技有限公司(以下统称"转让方")签署《杭州集智机电股份有限公司对浙江谱麦科技有限公司之收购意 向协议》(以下简称"《收购意向协议》")，公司拟以支付现金的方式收购浙江谱麦科技有限公司(以下简 称"标的公司"或"谱麦科技")不低于51%股权并取得谱麦科技控股权。 谱麦科技自成立以来主要专注于机器人性能检测与校准技术研究与应用，提供机器人性能检测与校准、 机器人抖动测量与分析、机器人可靠性试验、机器人动力学参数辨识和优化分析、机器人性能视觉检测 系统等产品，为客户提供定制化智能装备检测解决方案及可靠性分析和试验服务。 ...

Core Viewpoint - The company, Jizhi Co., announced its intention to acquire at least 51% of Zhejiang Pumai Technology Co., a leading enterprise in the field of robot performance testing and calibration in China, through a cash payment [1] Group 1 - The acquisition aims to gain control over Pumai Technology, enhancing the company's capabilities in the robot sector [1] - There is a strong business synergy between the company and Pumai Technology, which is expected to benefit the overall operations [1] - Successful implementation of the acquisition will allow the company to expand its business from core component testing to complete robot testing, thereby improving its market competitiveness [1]

格隆汇12月24日丨集智股份(300553.SZ)公布，公司与自然人陈章位、沈慧、张翔、杭州亿恒科技有限 公司（统称"转让方"）签署《杭州集智机电股份有限公司对浙江谱麦科技有限公司之收购意向协议》， 公司拟以支付现金的方式收购浙江谱麦科技有限公司（简称"标的公司"或"谱麦科技"）不低于51%股权 并取得谱麦科技控股权（最终收购比例以正式协议确定的比例为准）。 公司专注于全自动平衡机、测试机的研发、生产和销售，全自动平衡机主要用于回转零部件不平衡量的 检测及自动修正，是保证设备安全稳定运行的重要手段。近年来，机器人产业的快速兴起为公司业务拓 展了新的应用领域，公司开发的多款核心设备顺利与机器人零部件厂商建立了业务合作关系，拥有良好 的客户渠道。谱麦科技一直专注于机器人性能检测与校准技术研究与应用，在机器人整机层面的性能检 测与校准方面具备丰富的技术储备和开发经验，是中国机器人性能检测与校准领域产品的领先企业，谱 麦科技与公司存在较强的业务协同性。若本次收购顺利实施，公司将在机器人领域实现从核心零部件检 测业务到机器人整机检测业务的发展布局，提升公司在机器人领域的业务开拓能力和市场竞争力，推动 公司在机器人产业的 ...

格隆汇12月24日丨集智股份(300553.SZ)公布，公司与自然人陈章位、沈慧、张翔、杭州亿恒科技有限 公司（统称"转让方"）签署《杭州集智机电股份有限公司对浙江谱麦科技有限公司之收购意向协议》， 公司拟以支付现金的方式收购浙江谱麦科技有限公司（简称"标的公司"或"谱麦科技"）不低于51%股权 并取得谱麦科技控股权（最终收购比例以正式协议确定的比例为准）。 公司专注于全自动平衡机、测试机的研发、生产和销售，全自动平衡机主要用于回转零部件不平衡量的 检测及自动修正，是保证设备安全稳定运行的重要手段。近年来，机器人产业的快速兴起为公司业务拓 展了新的应用领域，公司开发的多款核心设备顺利与机器人零部件厂商建立了业务合作关系，拥有良好 的客户渠道。谱麦科技一直专注于机器人性能检测与校准技术研究与应用，在机器人整机层面的性能检 测与校准方面具备丰富的技术储备和开发经验，是中国机器人性能检测与校准领域产品的领先企业，谱 麦科技与公司存在较强的业务协同性。若本次收购顺利实施，公司将在机器人领域实现从核心零部件检 测业务到机器人整机检测业务的发展布局，提升公司在机器人领域的业务开拓能力和市场竞争力，推动 公司在机器人产业的 ...

集智股份公告，公司与自然人陈章位、沈慧、张翔、杭州亿恒科技有限公司签署《杭州集智机电股份有 限公司对浙江谱麦科技有限公司之收购意向协议》，拟以支付现金的方式收购浙江谱麦科技有限公司不 低于51%股权并取得谱麦科技控股权。 ...

| 证券代码：300553 | 证券简称：集智股份 | 公告编号：2025-075 | | --- | --- | --- | | 债券代码：123245 | 债券简称：集智转债 | | 杭州集智机电股份有限公司 关于签署股权收购意向协议的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 1、近日，杭州集智机电股份有限公司（以下简称"公司"）与自然人陈章 位、沈慧、张翔、杭州亿恒科技有限公司（以下统称"转让方"）签署《杭州集 智机电股份有限公司对浙江谱麦科技有限公司之收购意向协议》（以下简称"《收 购意向协议》"），公司拟以支付现金的方式收购浙江谱麦科技有限公司（以下 简称"标的公司"或"谱麦科技"）不低于 51%股权并取得谱麦科技控股权（最 终收购比例以正式协议确定的比例为准）。 2、本次签署的《收购意向协议》系各方合作意愿的框架性、意向性约定， 各方尚未签署正式的收购协议，本次交易能否正式达成尚存在不确定性。在《收 购意向协议》履行过程中，仍存在因政策调整、市场环境变化以及公司基于后续 尽职调查与协商的实际情况，而使收购方案变更或推进未达预期的风 ...

Group 1 - The core viewpoint of the news is that Jizhi Co., Ltd. has seen a stock price increase of 5.04%, reaching 37.93 CNY per share, with a total market capitalization of 4.211 billion CNY [1] - Jizhi Co., Ltd. specializes in the research, design, production, and sales of fully automatic balancing machines, testing machines, and automation equipment, with its main business revenue composition being 65.02% from balancing machines and accessories, 23.79% from automation equipment and accessories, and 11.20% from software information systems [1] Group 2 - Wan Jia Fund has a significant holding in Jizhi Co., Ltd., with its Wan Jia Advanced Manufacturing Mixed Fund A (018184) holding 158,000 shares, accounting for 3.64% of the fund's net value, making it the ninth largest holding [2] - The Wan Jia Advanced Manufacturing Mixed Fund A (018184) has achieved a year-to-date return of 18.71% and a one-year return of 17.09%, ranking 4482 out of 8088 and 4657 out of 8058 respectively [2] - The fund manager, Zhang Xichen, has been in position for 2 years and 270 days, with the fund's total asset size at 637 million CNY and a best return of 41.85% during his tenure [3]

证券日报网讯 12月22日晚间，集智股份发布公告称，公司2025年第三次临时股东会审议通过《关于提 请股东会授权董事会办理股权激励相关事宜的议案》等。 （文章来源：证券日报） ...